Cell Robotics signs with Sanwa Kagaku Kenysuho (SKK) for Japan:
This article was originally published in Clinica
Executive Summary
Cell Robotics' Lasette laser finger perforator will be distributed in Japan by Sanwa Kagaku Kenysuho (SKK), a subsidiary of the Suzuken pharmaceutical distribution company. SKK is a leading supplier of diabetic products, with around $250 million sales annually and has 50% of the glucose measuring strip market. SKK will seek Japanese approval for the product. The Lasette is the only FDA-approved laser blood extraction device.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.